Clinical Trials Directory

Trials / Unknown

UnknownNCT01207531

MiRNAs Evaluate the Prognosis of Sepsis

miRNA in the Evaluation of the Value of Sepsis Prognosis Prospective Observational Study

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Sepsis is a common cause of death in intensive care unit, timely and accurate diagnosis and treatment directly affect the survival rate. MiRNA is a post-transcriptional small RNA which regulate mRNA expression. The present study was designed to screen several miRNA by microarray which evaluate the sepsis prognosis in order to be a new target for the treatment of sepsis.

Detailed description

The study is a non-intervention, prospective observational study. Purpose of this sudy is to screening several miRNAs by microarray which can evaluate the prognosis of sepsis . We will collect serum samples from patients with sepsis in SICU, RICU and EICU of 301 Hospital since September 2009 , and then use the chip and qRT-PCR to Screen miRNAs which can evaluate the prognosis of sepsis, and statistical analysis the miRNAS expression correlation with SOFA score.

Conditions

Timeline

Start date
2010-07-01
Primary completion
2010-11-01
Completion
2011-04-01
First posted
2010-09-23
Last updated
2010-09-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01207531. Inclusion in this directory is not an endorsement.

MiRNAs Evaluate the Prognosis of Sepsis (NCT01207531) · Clinical Trials Directory